IceCure Medical Ltd research, develops, and markets minimally invasive cryoablation systems for women's health and oncology markets. It offers ProSense system, a cryoablation solution for breast tumors. The company was founded in 2006 and is headquartered in Caesarea, Israel. The company trades on NCM exchange. The company headquarter is located in Caesarea, Israel. The company was established in the 2006.

TickerICCM
Long NameIceCure Medical Ltd
Short NameIceCure Medical Ltd.